Combined modality therapy for advanced head and neck cancer

Area of Science:

• Oncology
• Head and Neck Cancer Research
• Chemotherapy and Radiation Oncology

Background:

• Advanced squamous cell carcinoma of the head and neck (stages III-IV) presents a significant treatment challenge.
• Neoadjuvant chemotherapy followed by definitive local treatment is a strategy explored to improve outcomes.

Purpose of the Study:

• To evaluate the efficacy of a neoadjuvant chemotherapy regimen (cis-platinum, Oncovin, bleomycin) followed by surgery and/or radiotherapy in previously untreated patients with stage III-IV head and neck squamous cell cancer.
• To assess the impact of treatment response on overall survival.

Main Methods:

• A cohort of 75 previously untreated patients with stage III-IV head and neck squamous cell cancer received two cycles of chemotherapy with cis-platinum, Oncovin, and bleomycin.
• Patients then underwent radical surgery, radiotherapy, or a combination of both based on their response and disease status.
• Treatment response (complete or partial) was assessed, and overall survival was analyzed in relation to response and prognostic factors.

Main Results:

• A high overall response rate of 80% (complete and partial responses) was observed following chemotherapy.
• Radical surgery was feasible in 36 patients.
• Statistically significant improvement in overall survival was noted for patients achieving complete or partial response to chemotherapy compared to those with minimal or no response.
• Well to moderately differentiated tumors and stage III disease were associated with a better prognosis than poorly differentiated tumors and stage IV disease.

Conclusions:

• Neoadjuvant chemotherapy with cis-platinum, Oncovin, and bleomycin followed by surgery and/or radiotherapy is an effective strategy for stage III-IV head and neck squamous cell cancer.
• Chemotherapy response is a significant predictor of improved overall survival in this patient population.
• Tumor differentiation and disease stage remain important prognostic factors influencing patient outcomes.